Emerging immunotherapies for kidney cancer - European Medical Journal

Emerging immunotherapies for kidney cancer

Oncology
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Thomas Powles. MBBS, MRCP, MD, of Barts Cancer Institute, Queen Mary University of London, London, UK, provides an overview of promising novel immunotherapeutic strategies that are currently under investigation for the treatment of patients with kidney cancer.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now